Archive seminar Series
Seminar Series "Seminars in Lipid Signalling"
SFB 1039 Signalling by fatty acid derivatives and sphingolipids in health and disease
Date | Speaker | Topic |
---|---|---|
04.02.2014 |
Prof. Dr. Dagmar Kratky
Center of Molecular Medicine Medical University of Graz |
Cellular and systemic adaptations of defective lipolysis: lessons from knockout mouse models |
18.03.2014 |
Prof. Dr. Isabelle Maridonneau Parini Institut de Pharamacologie et de Biologie Structurale CNRS UMR5089 Toulouse, France |
Molecular and cellular mechanisms of macrophage migration in 3-dimensional environments and HIV-1 hijacking |
22.04.2014 |
Prof. Dr. Georg Reiser Department of Neurobiochemistry, part of Magdeburg University's Faculty of Medicine |
Lipids in Neurodegeneration and protection: The lipid sensors PPAR (peroxisome proliferator-activated receptors) and the iPLA2 |
06.05.2014 |
Prof. Dr. Olivier Cuvillier, PhD
IPBS, Institute of Pharmacology and Structural Biology Department of Cancer Biology. Toulouse, France |
Sphingosine 1-phosphate in the regulation of hypoxia in cancer |
03.06.2014 |
Prof. Dr. Sibylle Schneider-Schaulies Julius Maximilian University of Würzburg Institute of Virology and Immunobiology |
The role of sphingomyelinase activation in Measles Virus induced T cell paralysis: modulation of activation thresholds? |
11.06.2014 |
William B. Campbell, Ph.D. Professor and Chairman Department of Pharmacology and Toxicology Medical College of Wisconsin, Milwaukee, USA |
Inducible Endothelium-derived Hyperpolarizing factor: Adapting vasodilation to physiological changes . |
01.07.2014 |
Prof. Dr. Rolf Müller Institute of Molecular Biology and Tumor Research (IMT) Philipps University Marburg |
Regulation of tumorigenesis-associated functions by the nuclear receptor PPARβ/δ |
05.08.2014 |
Prof. Dr. Stefan Uhlig RWTH Aachen Faculty of Medicine Director of the Institute of Pharmacology and Toxicology |
The multiple roles of the acid sphingomyelinase in sepsis and lung injury |
02.09.2014 |
Prof. Dr. Bodo Levkau Institute of Pathophysiology, Center of Internal Medicine University of Essen Medical School |
Sphingosine-1-phosphate in Atherosclerosis injury |
07.10.2014 |
Prof. Dr. Assia Shisheva, Professor of Physiology Wayne State University School of Medicine Detroit, USA 540 E. Canfield Av., Detroit |
PtdIns3, 5P2 and PtdIns5P: Enzymology, Signalling and Disease |
04.11.2014 |
Prof. Dr. Tobias Hartmann Professor for Experimental Neurology at the Saarland University |
Crossing the line - lipids in Alzheimer’s disease prevention and progression |
02.12.2014 |
Prof. Dr. Bernhard Hermann Rauch Institute of Pharmacologie, University of Greifswald |
Modulation of the sphingosine-1-phosphate pathway by coagulation factors |
12.02.2015 Bldg. 22, aud. 2 |
Prof. Dr. Dr. Detlef Schuppan Professor für Molekulare und Translationale Medizin (Fibrose- und Zöliakieforschung) an der Johannes Gutenberg-Universität Mainz. Professor of Medicine and Senior Visiting Scientist Harvard Medical School. Direktor Zöliakie- und Dünndarmzentrum |
Antifibrotic therapies for liver fibrosis: from bench to bedside |
03.03.2015 Bldg. 74, room 4.107 |
Prof. Dr. Hermann-Josef Gröne Zelluläre und Molekulare Pathologie Deutsches Krebsforschungszentrum Heidelberg |
Interplay of Transcription Factors and Sphingolipids |
14.04.2015 Bldg. 74, room 4.107 |
PD Dr. med. Andreas Vlachos Institut für klinische Neuroanatomie Goethe-Universität Frankfurt Dr. Senckenbergische Anatomie Neuroscience Center Frankfurt |
Role of Sphingosine-1-phosphate receptor signaling in denervation-induced dendritic plasticity |
12.05.2015 Bldg. 74, room 4.107 |
Professor Dr. Erich Gulbins Universitätsklinikum Essen Institut für Molekularbiologie (Tumorforschung) |
Sphingolipids in Cystic Fibrosis |
11.06.2015 Bldg. 22, aud. 2 |
Prof. Dr. Tobias Hartmann Deutsches Institut für Demenzprävention (DIDP) Experimental Neurology, Medical Campus of the Saarland University |
Crossing the line - lipids in Alzheimer’s disease prevention and progression |
23.07.2015 18 Uhr, Bldg. 22 |
Prof. Dr. rer.nat.Burkhard Kleuser Director of the Institute of Nutritional Science, Faculty of Mathematics and Natural Science, Universität Potsdam (Germany) |
Role of Sphingosine 1-phosphate in Insulin-sensitive tissues |
29.09.2015 Bldg. 74, room 4.107 |
Nader G Abraham, PhD., Dr. H.C., FAHA Professor of Medicine and Pharmacology New York Medical College |
EETs and 20-HETE are intracellular lipid-mediators that differentially regulate obesity and vascular diseases |
08.10.2015 Bldg. 22, aud. 2 |
Prof. Dr. Enrico Rovati Chief, Laboratory of Molecular Pharmacology Department of Pharmacological and Biomolecular Sciences, University of Milan |
Time for a new twist in NSAID pharmacology: the thromboxane prostanoid receptor at stage |
13.10.2015 Bldg. 74, room 4.107 |
Prof. Dr. David H. Thompson Department of Chemistry Purdue University |
Interfacial Design in Drug Delivery and CryoEM – Plasmalogen Reaction Dynamics and Novel Tools for Single Particle Reconstruction Analysis |
24.11.2015 Bldg. 74, room 4.107 |
Prof. Dr. Charles A. Dinarello Division of Infectious Diseases University of Colorado |
IL-37, the IL-1 Family Member that we never expected |
01.12.2015 18:00 Uhr Bldg. 22, PE-Hörsaal |
Prof. Timothy T. Hla Center for Vascular Biology Weill Cornell Medical College, Cornell University, New York, USA |
Adventures with Bioactive Lipids |
01.12.2015 Bldg. 74, room 4.107 |
Professor Dr. Johannes Kornhuber Universitätsklinikum Erlangen AöR Psychiatrische und Psychotherapeutische Klinik |
Sphingolipids in psychiatric disorders |
08.12.2015 Bldg. 74, room 4.107 |
Dr. rer. nat. Ina Maria Schießl Universität Regensburg |
Effects of Angiotensin II on the glomerular filtration barrier |
09.12.2015 Bldg. 74, room 4.107 |
Dr. Alexander Carpinteiro Universitätsklinikum Essen |
The role of acid sphingomyelinase in tumor metastasis |
10.12.2015 Bldg. 22, aud. 2 |
Prof. Dr. Rudolf Zechner Karl-Franzens-Universität Graz Institut für Molekulare Biowissenschaften |
tba. |
25.02.2016 18 h |
Eric Camerer, PhD Assistant Professor Cardiovascular Research Center Hôpital europén Georges-Pompidou Paris, Frankreich |
Roles of circulating sources of sphingosine-1-phosphate in the regulation of vascular integrity and tone |
15.03.2016 |
Professor Mark Exley University of Manchester Institute for Pharmaceutical Chemistry |
Understanding and Exploiting lipid-reactive NKT cell populations in health and disease |
22.03.2016 |
Professor Dr. Stefan Knapp Goethe-University Frankfurt Institute for Pharmaceutical Chemistry |
Application of chemical probes as tools for target validation |
28.04.2016 18 h H27 (Hörsaal der Anatomie / Ernst und Berta Scharrer-Hörsaal) |
Professor Mario Romano University "G. D'Annunzio" Chieti, Italy |
Pro-resolution lipid mediators and receptors: Novel signaling pathways and regulatory mechanisms. |
24.05.2016 |
Per Haberkant, PhD Leiden University | Leiden Institute of Chemistry (LIC) Department Biochemistry Niederlande |
A Quantitative Map of Cellular Sphingolipid-Protein Complexes Revealed by Large-Scale Systematic Profiling |
31.05.2016 |
Professor Joan Massagué Direktor, Sloan Kettering Cancer Center New York |
Contextual determinants of TGFß signalling |
07.06.2016 |
Professor Dr. med. Hermann-Joseph Pavenstädt Universitätsklinikum Münster |
Role of the WWC-Hippo signaling in the kidney |
21.06.2016 |
Professor Dr. Johannes Kornhuber Universitätsklinikum Erlangen AöR Psychiatrische und Psychotherapeutische Klinik |
Sphingolipids in psychiatric disorders. |
12.07.2016 WIRD VERSCHOBEN |
Carsten Schultz Group Leader and Senior Scientist Cell Biology & Biophysics Unit EMBL Heidelberg |
Chemical biology tools to study lipid signaling |
12.10.2016 |
Professor Per-Johan Jakobsson Uppsala University Karolinska Institutet Stockholm Sweden |
Recent findings on the impact of mPGES-1 inhibition in cancer, inflammation and the cardiovascular system |
25.10.2016 |
Sara Gonçalves, MD Institut Imagine Inserm U1163, Paris |
SGPL1 mutations as a novel cause of steroid resistant nephrotic syndrome, adrenal insufficiency and ichtyosis in humans |
15.11.2016 |
Professor Christer Betsholtz Uppsala University Karolinska Institutet Stockholm Sweden |
Microvascular pericytes and their role in the blood-brain barrier |
28.03.2017 |
Prof. John Whitelock Graduate School of Biomedical Engineering The University of New South Wales Sydney, Australia |
Proteoglycans: Dynamic complex molecules supporting tissue and organ architecture whilst promoting biological diversity |
18.04.2017 12 Uhr |
Professor Dr. Peter Mertens Otto-von-Guericke-Universität Magdeburg Universitätsklinik für Nieren- und Hochdruckkrankheiten |
Translationale Aspekte bei Kälteschockproteinen: eine Bestandsaufnahme |
16.05.2017 17 Uhr |
Prof. Dr. rer. nat. Andreas Reichert Institut für Biochemie und Molekularbiologie University Hospital Düsseldorf |
Mitochondrial quality control: from mitochondrial dynamics to mitophagy |
07.06.2017 17 Uhr |
Prof. Dr. Anja U. Bräuer Universität Oldenburg |
Phospholipid Modifying Proteins in the Brain |
12.06.2017 16 Uhr |
Prof. Dr. med. Stefan Bittner Universitätsmedizin der Johannes Gutenberg-Universität Mainz |
Lipid-sensitive potassium channels regulate blood-brain barrier integrity in multiple sclerosis |
20.06.2017 12 Uhr |
Ivan Yudushkin, Ph.D. Medical University of Vienna |
Restraining promiscuous Akt: Binding to PI(3,4,5)P3 restricts Akt kinase activity to cellular membranes |
04.07.2017 12 Uhr |
Prof. Dr. med. Ulrich Kintscher Charité - Universitätsmedizin Berlin |
Regulation of the Cardiac Lipidome in Chronic Heart Failure - The Role of Adipose Tissue Lipolysis |
26.09.2017 12 Uhr |
Dr. rer. nat. Viola Nordström Department of Cellular and Molecular Pathology (G130) Interdisciplinary Center for Neurosciences (IZN) Heidelberg University |
Neuronal gangliosides in body weight regulation and Alzheimer’s disease |
05.12.2017 12 Uhr |
Prof. Dr. Christoph Thiemermann Queen Mary University London |
New therapeutic strategies for trauma-haemorrhage |
19.12.2017 12 Uhr |
Prof. Dr. Nurcan Üçeyler, MHBA Neurologische Klinik Universitätsklinik Würzburg |
Pain in Fabry disease – clinical and basic science approaches |